8-K: HealthStream Reports Record Q2 Revenue, Boosts 2026 Outlook

HealthStream announced strong second quarter 2026 results, featuring record revenue of $83.7 million, up 12.5%, and increased net income, leading to an updated and slightly improved full-year financial guidance.

Summary

• HealthStream reported record revenue of $83.7 million for the second quarter of 2026, a 12.5% increase compared to $74.4 million in Q2 2025.
• Operating income rose by 41.4% to $8.3 million, and net income increased by 23.8% to $6.7 million.
• Diluted earnings per share (EPS) were $0.23, up from $0.18 in the prior year's second quarter.
• Adjusted EBITDA grew 16.9% to $20.6 million.
• The company updated its full-year 2026 guidance, raising the revenue range to $327.0 $332.0 million and the Adjusted EBITDA range to $74.0 $78.0 million.
• A quarterly cash dividend of $0.035 per share was declared, payable on August 28, 2026.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a positive report, with strong revenue growth, improved profitability, and an updated, slightly raised full-year guidance, indicating solid operational performance and positive momentum.

Positives

• Record quarterly revenue of $83.7 million, up 12.5% year-over-year.
• Significant increase in operating income (41.4%) and net income (23.8%).
• Improved diluted EPS to $0.23 from $0.18.
• Strong growth in Adjusted EBITDA, up 16.9%.
• Positive impact from acquisitions of Virsys12 and MissionCare Collective contributing $3.1 million to revenue growth.
• Resolution of previously constrained estimates under a customer contract added $2.0 million to revenue.
• Updated full-year 2026 revenue guidance increased to $327.0 $332.0 million from $323.0 $330.0 million.
• Full-year 2026 Adjusted EBITDA guidance increased to $74.0 $78.0 million from $73.0 $77.0 million.

Negatives

• Increased operating expenses including personnel costs, third-party software, sales commissions, marketing, cloud hosting, and royalties.
• Amortization expense from fourth quarter 2025 acquisitions.

Risks

• Forward-looking statements are subject to known and unknown risks, uncertainties, and other factors that could cause actual results to differ materially.
• Potential for negative economic conditions, changes in U.S. policy, adverse developments in the technology and healthcare industry, tariff and trade-related developments, inflationary pressures, and geopolitical instability.
• Legal requirements and contractual restrictions could affect the continuation of the quarterly cash dividend policy.
• Risks referenced in the Company's Annual Report on Form 10-K for the year ended December 31, 2025, and other SEC filings.

Future Outlook

The company is updating its full-year 2026 guidance, projecting revenue between $327.0 million and $332.0 million, net income between $19.5 million and $22.2 million, and Adjusted EBITDA between $74.0 million and $78.0 million. Capital expenditures are expected to be between $31.0 million and $34.0 million.

Management Comments

• "In the second quarter of 2026, HealthStream delivered record revenue of $83.7 million, up 12.5%, and adjusted EBITDA of $20.6 million, up 16.9%, compared to the second quarter of 2025."
• "This performance gives us the flexibility to continue investing in our hStream platform and products that we believe will drive durable, long-term growth as we build an even stronger ecosystem for the healthcare organizations and professionals we serve."

Industry Context

StockSavvy.ai notes that HealthStream's performance aligns with a trend of increasing demand for healthcare technology platforms that enhance clinical workforce efficiency and patient care, particularly in the post-pandemic environment. The company's focus on its hStream platform suggests a strategic investment in integrated solutions.

Stakeholder Impact

• Shareholders: Benefit from increased EPS, a declared quarterly dividend, and potentially higher stock value due to improved financial performance and guidance.
• Employees: May benefit from company growth and investments in platforms, potentially linked to performance-based incentives.
• Customers: Benefit from enhanced clinical workforce solutions and platform improvements.
• Creditors: Company has no outstanding indebtedness from borrowed money, indicating a strong balance sheet from a credit perspective.

Next Steps

• Continue investing in the hStream platform and products.
• Hold a conference call on August 4, 2026, to discuss Q2 2026 results.
• Pay quarterly cash dividend of $0.035 per share on August 28, 2026.

Key Dates

Recommendation

The company is performing well with record revenue and improved profitability, and has slightly raised its full-year guidance. However, the market may have already priced in this positive performance, and the company faces ongoing risks and increased operating expenses. A 'hold' recommendation reflects a balanced view of current performance against future uncertainties and market expectations.

Keywords

healthcare technology, clinical workforce solutions, revenue growth, earnings per share, adjusted EBITDA, dividend, financial results, guidance